GLYCOMIMETICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Glycomimetics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q4 2024.
  • Glycomimetics Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$7.22M, a 20.4% increase year-over-year.
  • Glycomimetics Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$37.9M, a 2.66% decline year-over-year.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$37.9M, a 2.66% decline from 2023.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$36.9M, a 21% increase from 2022.
  • Glycomimetics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$46.7M, a 26.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$37.9M -$7.22M +$1.86M +20.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 -$39.7M -$9.82M -$622K -6.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$39.1M -$10.1M -$1.84M -22.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$37.3M -$10.7M -$377K -3.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$36.9M -$9.08M +$1.17M +11.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 -$38.1M -$9.2M -$679K -7.96% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$37.4M -$8.26M +$5.01M +37.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$42.4M -$10.4M +$4.29M +29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$46.7M -$10.2M +$7.18M +41.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$53.9M -$8.52M +$8.81M +50.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$62.7M -$13.3M +$1.13M +7.86% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$63.8M -$14.7M -$379K -2.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$63.4M -$17.4M -$1.86M -11.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 -$61.6M -$17.3M -$3.61M -26.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$58M -$14.4M -$320K -2.28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$57.6M -$14.3M -$6.61M -86.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$51M -$15.6M -$836K -5.68% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 -$50.2M -$13.7M -$471K -3.55% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$49.7M -$14.1M +$1.75M +11.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$51.5M -$7.66M +$6.42M +45.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$57.9M -$14.7M -$819K -5.89% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$57.1M -$13.3M -$1.68M -14.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$55.4M -$15.8M -$4.55M -40.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$50.8M -$14.1M -$2.57M -22.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$48.3M -$13.9M -$4.65M -50.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$43.6M -$11.6M -$3.63M -45.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$40M -$11.3M -$3.14M -38.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$36.9M -$11.5M -$3.58M -45.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$33.3M -$9.26M -$929K -11.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$32.4M -$7.95M -$95.4K -1.22% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$32.3M -$8.14M -$70.2K -0.87% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$32.2M -$7.93M -$376K -4.98% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$31.8M -$8.33M +$553K +6.23% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$32.4M -$7.85M -$687K -9.58% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$31.7M -$8.07M -$18.5M -178% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$13.2M -$7.55M -$446K -6.27% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$12.8M -$8.88M -$1.49M -20.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$11.3M -$7.17M -$550K -8.32% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$10.7M $10.4M +$2.4M +30% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$13.1M -$7.11M -$2.01M -39.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$11.1M -$7.39M -$3.53M -91.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$7.6M -$6.62M -$2.92M -78.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$4.68M $7.99M +$11.5M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$16.2M -$5.1M -$5.56M -1210% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$10.6M -$3.87M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$3.7M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$3.5M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 $460K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.